Kleo Pharmaceuticals Presents Preclinical Proof-of-Concept Data on a Novel Chemical Conjugation Platform (MATE™) at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting

NEXT STORY
Celldex Presents Data from Oncology Portfolio at SITC 2020
PREV STORY
Arch Therapeutics’ AC5 Advanced Wound System Presented at the 2020 Symposium on Advanced Wound Care (SAWC) Fall
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ePharmacy Market Size Worth US$370 Million by 2031: Visiongain Research Inc.

author_avatar
NASDAQ Market News

OSE Immunotherapeutics Publishes New Efficacy Data on FR104, CD28-Antagonist Immunotherapy

            FR104 shown to be efficacious in a preclinical bone ...

author_avatar
NASDAQ Market News

Corbus Pharmaceuticals Presents 1-Year Systemic Sclerosis and 6-Month Dermatomyositis Data from Open-Label Extension of Phase 2 Lenabasum Studies at EULAR 2018

Multiple key efficacy outcomes further improved in open-label extensions of systemic sclerosis (SSc) and ...

author_avatar
NASDAQ Market News